Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania.
Jefferson College of Population Health, Philadelphia, Pennsylvania.
Prev Chronic Dis. 2020 Dec 17;17:E159. doi: 10.5888/pcd17.200324.
Hepatitis delta virus (HDV) is a serious coinfection of the hepatitis B virus (HBV) that is estimated to affect between 48 to 72 million people worldwide. Data are limited on the informational needs of people living with HDV. The Hepatitis B Foundation, a US-based nonprofit organization that provides support to people living with HBV and HDV, receives emails (queries) as part of a helpline, a service to provide information, resources, and support to people affected by HBV and HDV.
Query content was analyzed to assess the impact of HDV at the individual level. A total of 65 HDV-related queries from 17 countries were received from October 2016 to January 2019, and all were analyzed for this study.
Thematic analysis of queries indicated 4 dominant themes. Three were related to a need for information about 1) the disease and prevention of it, 2) disease symptoms and outcomes, and 3) treatment options. The fourth theme was related to barriers and quality of life. Individuals requested information on treatment options, medication access, diagnostic test interpretation, and clinical trials.
Our study highlights the needs and lived experience of patients with HDV and summarizes critical information gaps. Findings can inform health care providers, public health professionals, and the pharmaceutical and biotechnology industries about the informational needs and lived experiences of individuals living with HDV and help create future HDV-related educational resources, care, and clinical trials.
乙型肝炎病毒(HBV)的一种严重的合并感染是乙型肝炎病毒(HBV),估计全世界有 4800 万至 7200 万人受到影响。关于携带 HDV 人群的信息需求数据有限。乙型肝炎基金会是一家总部设在美国的非营利组织,为 HBV 和 HDV 感染者提供支持,该组织通过热线接收电子邮件(查询),作为为 HBV 和 HDV 感染者提供信息、资源和支持的服务的一部分。
分析查询内容,评估 HDV 在个体层面的影响。2016 年 10 月至 2019 年 1 月,该基金会共收到来自 17 个国家的 65 份与 HDV 相关的查询,本研究对所有查询进行了分析。
查询的主题分析表明有 4 个主要主题。其中三个与以下方面的信息需求有关:1)疾病及其预防,2)疾病症状和结果,以及 3)治疗方案。第四个主题与障碍和生活质量有关。个人请求提供有关治疗方案、药物获取、诊断测试解释和临床试验的信息。
我们的研究强调了 HDV 患者的需求和生活体验,并总结了关键的信息差距。研究结果可以为医疗保健提供者、公共卫生专业人员以及制药和生物技术行业提供有关携带 HDV 个体的信息需求和生活体验的信息,并有助于为未来的 HDV 相关教育资源、护理和临床试验创造条件。